CARD9 Mutations Linked to Subcutaneous Phaeohyphomycosis and TH17 Cell Deficiencies.
Xiaowen Wang,Wenyan Wang,Zhimiao Lin,Xiaolin Wang,Ting Li,Jin Yu,Wei Liu,Zhongsheng Tong,Yonghao Xu,Junling Zhang,Liping Guan,Lanlan Dai,Yong Yang,Wenling Han,Ruoyu Li
DOI: https://doi.org/10.1016/j.jaci.2013.09.033
2013-01-01
Abstract:Phaeohyphomycosis is a group of superficial, cutaneous, subcutaneous, or systemic infections caused by more than 100 species of diverse dematiaceous fungi. It is characterized by dematiaceous yeast-like cells, hyphae, and pseudohyphae in tissue, while sclerotic bodies, characteristics of chromoblastomycosis, are absent.1Li R.Y. Wang D.L. Studies on phaeohyphomycosis and its causative agents in China.Jpn J Med Mycol. 1996; 37: 135-141Crossref Scopus (16) Google Scholar Phialophora verrucosa, one of the Phialophora species, can be isolated from soil, wood, and rotting vegetation worldwide and has sometimes been reported to cause subcutaneous phaeohyphomycosis.2Gao L.J. Yu J. Wang D.L. Li R.Y. Recalcitrant primary subcutaneous phaeohyphomycosis due to Phialophora verrucosa.Mycopathologia. 2013; 175: 165-170Crossref PubMed Scopus (10) Google Scholar During the last decade, host defense against fungal infections has been extensively studied. Our understanding of genetic and immune deficiencies that predispose to chronic mucocutaneous candidiasis has substantially advanced.3Engelhardt K.R. Grimbacher B. Mendelian traits causing susceptibility to mucocutaneous fungal infections in human subjects.J Allergy Clin Immunol. 2012; 129 (306-7): 294-305Abstract Full Text Full Text PDF PubMed Scopus (55) Google Scholar However, the genetic and immunologic defects in patients with phaeohyphomycosis have not been investigated. Here, we report 4 Chinese patients with subcutaneous phaeohyphomycosis caused by P verrucosa with CARD9 mutations and TH17 cell deficiencies. Four patients presenting with persistent red plaques and nodules on their cheeks and faces were recruited in our study (Fig 1, A-C). The clinical manifestations and the outcomes of the 4 patients are summarized in Table E1 in this article's Online Repository at www.jacionline.org. Histological examination revealed intense inflammatory infiltrations with dematiaceous hyphae (Fig 1, D). From tissue cultures, P verrucosa was isolated and identified by the morphological characteristics of black colonies in macroscopic appearance and septate hyphae with typical Phialophora type of sporulation in microscopic appearance (Fig 1, E and F), which was confirmed by internal transcribed spacer region nucleotide sequencing (Genbank Accession No. KF360974, KF471126, KF360975, and JX233482). There were no other chronic or opportunistic infections detected or reported in all the patients before their presentation, and they could not recall any trauma. A history of consanguineous marriage was denied. The diagnosis of phaeohyphomycosis caused by P verrucosa was made on the basis of the above clinical, histopathological, and mycological findings. As is known, both chromoblastomycosis and phaeohyphomycosis can be caused by dematiaceous fungi, but the clinical manifestations and prognosis are different.1Li R.Y. Wang D.L. Studies on phaeohyphomycosis and its causative agents in China.Jpn J Med Mycol. 1996; 37: 135-141Crossref Scopus (16) Google Scholar Patients with P verrucosa–associated subcutaneous phaeohyphomycosis, as demonstrated in our cases, have a relatively early onset, no trauma history, and no known immunocompromised conditions and are resistant to various systemic antifungal agents with remittent aggravation. These clinical features highly suggest that some underlying genetic defects and the subsequent immunodeficiencies should be considered, and thus we carried out whole-exome sequencing in 2 of the sporadic cases (patients 1 and 2). Written informed consent was obtained from all the patients and 6 ethnically matched healthy volunteers. Ethical approval for molecular genetic studies was obtained from the Clinical Research Ethics Committee of Peking University First Hospital. Genomic DNA was extracted from the peripheral blood leukocytes. Exome capture was carried out with SureSelect Human All Exon Kit (Agilent, Santa Clara, Calif), and then sequenced by using Hiseq2000 platform. To eliminate the nonpathogenic variants, we filtered out the single nucleotide variants and short insertions and deletions (indels) existing in in-house database and 3 public variation databases (dbSNP134, 1000 Genomes Project, and HapMap8). As a result, including indels, 1333 variants involving 1000 different genes and 1220 variants involving 943 different genes were detected in patient 1 and patient 2, respectively. When we compared these variants with the genes previously reported to be implicated in fungal infection,4Wang X.W. Lin Z.M. Gao L.J. Wang A.P. Wan Z. Chen W. et al.Exome sequencing reveals a signal transducer and activator of transcription 1 (STAT1) mutation in a child with recalcitrant cutaneous fusariosis.J Allergy Clin Immunol. 2013; 131: 1242-1243Abstract Full Text Full Text PDF PubMed Scopus (23) Google Scholar only 1 gene (CARD9) shared by both patients was found. Sanger sequencing was subsequently performed to validate these 3 variants involving CARD9 and to screen mutations of CARD9 in the other 2 patients. Briefly, 3 mutations of CARD9 were detected: 2 compound heterozygous mutations in patient 1 (c.191-192insTGCT and c.472C>T, p.L64fsX59 and p.Q158X) and 1 homozygous frameshift mutation (c.819-820insG, p.D274fsX60) in patients 2, 3, and 4 (see Fig E1, A, in this article's Online Repository at www.jacionline.org). No relationship or common relatives were reported in patients 2, 3, and 4, who were from different provinces and did not know each other before. We subsequently performed haplotype analysis in these 3 patients to determine whether mutation c.819-820insG was from one common ancestor. Twelve single nucleotide polymorphisms highly polymorphic in Asian populations nearby the mutation were chosen and genotyped. Unexpectedly, all 3 patients shared the same homozygous alleles in all 12 SNPs, suggesting a founder effect (see Table E2 in this article's Online Repository at www.jacionline.org). Parents and siblings of the patients were all healthy and heterozygous carriers of 1 corresponding mutation (the deceased parents of patients 3 and 4 were not enrolled; Fig E1, B). All these detected mutations were not found in 220 ethnically matched control subjects. Thus, CARD9 was selected as the most likely causative gene underlying phaeohyphomycosis in these patients. To verify the expression of CARD9 in our cases, we detected it in PBMCs of patients 1, 2, and 3 by using quantitative PCR and western blot. (Patient 4 was not enrolled in the following study because of traffic inconvenience.) Patients exhibited sufficient level of CARD9 mRNA transcripts compared with 5 healthy donors, thereby escaping from nonsense-mediated RNA decay (Fig E1, C). Contrarily, patients lacked the expression of the wild-type mature CARD9 protein, which further confirmed the consequences of premature termination codons in frameshift and nonsense mutations (Fig 2, A). CARD9 is a critical adaptor that can mediate Dectin-1, Dectin-2, and Mincle-induced NF-κB activation by forming the CARD9–BCL10–MALT1 complex in response to fungal infection.5Bertin J. Guo Y. Wang L. Srinivasula S.M. Jacobson M.D. Poyet J.L. et al.CARD9 is a novel caspase recruitment domain-containing protein that interacts with BCL10/CLAP and activates NF-kappa B.J Biol Chem. 2000; 275: 41082-41086Crossref PubMed Scopus (186) Google Scholar, 6Drummond R.A. Saijo S. Iwakura Y. Brown G.D. The role of Syk/CARD9 coupled C-type lectins in antifungal immunity.Eur J Immunol. 2011; 41: 276-281Crossref PubMed Scopus (161) Google Scholar CARD9 deficiencies may impair pivotal cytokine production in innate immune cells and the differentiation of TH17 cells. It was reported that CARD9-deficient mice were highly susceptible to Candida albicans infections.7Gross O. Gewies A. Finger K. Schafer M. Sparwasser T. Peschel C. et al.Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity.Nature. 2006; 442: 651-656Crossref PubMed Scopus (667) Google Scholar And homozygous loss-of-function nonsense mutation in CARD9 (Q295X) has been found to cause chronic mucocutaneous candidiasis in a large consanguineous family, with reduced TH17 cells and impaired immune response to Dectin-1 agonist.8Glocker E.O. Hennigs A. Nabavi M. Schaffer A.A. Woellner C. Salzer U. et al.A homozygous CARD9 mutation in a family with susceptibility to fungal infections.N Engl J Med. 2009; 361: 1727-1735Crossref PubMed Scopus (627) Google Scholar We then assessed the abundance of TH17 cells and the related cytokines in patients 1, 2, and 3. It was noteworthy in our observation that the percentages of TH17 cells (CD4+/IL-17+) in patients' PBLs were strikingly decreased, and so was the representative effector cytokines IL-17 and IL-22 in serum (Fig 2, B and C). The profound deficiencies of TH17 responses, as downstream consequences, might lead to the patients' suppressed antifungal immunity. As the key players in initiating and regulating adaptive immune responses, macrophages and dendritic cells (DCs) secrete cytokines to trigger the differentiation of TH17 cells.9Romani L. Immunity to fungal infections.Nat Rev Immunol. 2011; 11: 275-288Crossref PubMed Scopus (868) Google Scholar Therefore, we isolated monocytes from 3 healthy donors and patients 1 and 3, and induced them toward macrophages and immature DCs. Responses to P verrucosa spores were detected by the production of IL-6, TNF-α, IL-1β, and IL-23p19 in supernatants, which were essential for the differentiation, activation, and expansion of TH17 cells. When challenged with P verrucosa spores, both macrophages and DCs from patients secreted much lower cytokines than did those from control subjects (Fig 2, D and E). It is reasonable to speculate that CARD9 deficiencies cause the decreased production of cytokines from innate immune cells, which leads to the deficiencies of TH17 cells and consequently predisposes patients to recalcitrant subcutaneous P verrucosa infections. An intriguing feature of these patients is that distinct mutations in CARD9 did not give rise to Candida infections in our cases, despite its ubiquity in human skin. Whether CARD9 is indispensable in different fungal infections, as well as the association of genotype with phenotype, still needs further investigation. Taken together, our study showed CARD9 mutations in 4 patients with pheohyphomycosis with marked decreased proportions and cytokines of TH17 cells and impaired immune responses against P verrucosa, which further confirmed the pivotal role of CARD9 in antifungal defense. Our preliminary findings of P verrucosa linked, for the first time, CARD9 deficiencies with the susceptibility to opportunistic filamentous fungi, other than yeast or yeast-like fungi. What we have identified in this study will enrich the phenotypic spectrum of diseases underlying CARD9 deficiencies. We thank all of the patients and their family members for their participation in this study. We also thank Zhe Wan and Wei Chen for isolation and identification of the pathogen and Prof Dalong Ma, the director of Peking University Health Science Center, for supporting the project and advice on the paper. Table E1Summary of the clinical manifestations for the patientsPatientSexAge (y)Age at presentation (y)Clinical featuresOutcome1Male2113Progressive dark red plaques and nodules on his bilateral cheeks and earsOral itraconazole and intravenous amphotericin B once showed limited effect, but there was no complete healing. Now the lesions aggravated with subcutaneous disseminations.2Male176Gradually enlarged red plaques on his right cheekIntravenous amphotericin B followed by oral itraconazole for 2 y, with recurrence whenever withdrew the drug.3Female4320Slowly enlarged plaques and nodule on her right cheekSurgical excision of the nodule combined with oral itraconazole therapy for 1 y. It seemed effective, and she was still in treatment.4Male6448Severe violet plaque on his face and scalp, which involved his eyes and caused blindness 4 y agoOral itraconazole combined with terbinafine for half a year. The lesions improved slightly without satisfactory response. Open table in a new tab Table E2Haplotype analysis in patients 2, 3, and 4SNPLocation (hg19)Reference alleleAlternative alleleAllele frequency for samples from AsianPatient 2Patient 3Patient 4rs3812553Chr 9: 139256495GT0.10TTTrs10870201Chr 9: 139257147GC0.31CCCrs10870202Chr 9: 139257411TC0.32CCCrs45592338Chr 9: 139257422CG0.24GGGrs4073153Chr 9: 139259349AG0.31GGGrs3812555Chr 9: 139261933CT0.17TTTrs3812556Chr 9: 139261991AG0.24GGGrs59902911Chr 9: 139265088CT0.09TTTrs11145769Chr 9: 139265870GA0.10AAArs10781499Chr 9: 139266405GA0.30AAArs4077515Chr 9: 139266496CT0.31TTTrs4075760Chr 9: 139266697AG0.31GGG Open table in a new tab